CLOs on the Move

American Sports Medicine Institute

www.asmi.org

 
American Sports Medicine Institute is a Birmingham, AL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

GENEX Services

Bringing Together the Heart and Science of Medical Management Genex was founded in 1978 with the same directive it operates under today — helping injured workers return to their jobs in a safe and efficient manner through compassionate case management, thus reducing health care costs and disability expenses for our customers. Our medical and business professionals provide comprehensive care management and multicultural services from locations across the United States and Canada.

Versant Health

Versant Health, a wholly-owned subsidiary of MetLife, is one of the nation`s leading managed vision care companies serving more than 37 million members nationwide. Through our Davis Vision plans and Superior Vision plans, we help members enjoy the wonders of sight through healthy eyes and vision. Providing vision and eye health solutions that range from routine vision benefits to medical management, Versant Health has a unique visibility and scale across the total eye health value chain. As a result, members enjoy a seamless experience with access to one of the broadest provider networks in the industry and an exclusive frame collection. Commercial groups, individuals, third parties and health plans that serve government-sponsored programs such as Medicaid and Medicare are among our valued customers.

Genetic Alliance

Genetic Alliance is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Elcelyx Therapeutics

lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.

Innovation Place

Innovation Place is a Saskatoon, SK-based company in the Healthcare, Pharmaceuticals, & Biotech sector.